SUNY / University of the West Indies
The UB Center for Integrated Global Biomedical Sciences (CIGBS)
will be working with the SUNY Global Health Institute (GHI) to
build research opportunities in Jamaica and the Caribbean region.
An infectious diseases research center is a high priority for the
SUNY—University of the West Indies (UWI) collaboration.
Enabling Jamaica to become a regional hub, the research will
focus on microbiologic, immunologic and pharmacologic aspects
related to detection, epidemiology, diagnostics, treatment and
prevention of infectious diseases. It will partner with programs
such as the Global Virus Network, WHO and Global Fund and network
with the diabetes, digestive and liver disease and nanomedicine
programs noted below.
Clinical Trials and Translational Research Center
Biomedical clinical research requires an organized, monitored
and quality-assured program that encourages interaction among
faculty members, students, patients, funding agencies and the
pharmaceutical research industry. So the West Indies Ministry of
Health and UWI are collaborating to ensure that GLP, GCLP and ISO
accreditation standards are met and sustained. They will be looking
at data management systems along with the country's strategic plan
for health information technology and a digital records system.
Antimicrobial Resistance and Stewardship Program
Antibiotic resistance is an international public health
challenge that requires immediate attention. A complex dynamic
exists between the procurement, clinical use, monitoring and
development of resistance and patient outcomes. Key steps in the
formation of the antimicrobial resistance and stewardship program
- Immediate translational research on pharmacologic factors that
contribute to poor outcomes in complex patients
- The role of biosurfaces
- Development of an antimicrobial resistance laboratory at the
University of the West Indies
- Development of a health information technology plan that
integrates antibiotic usage with laboratory reporting of
antimicrobial resistance with data analytics and outcomes
An integrated approach is critically needed to implement the
Antimicrobial Stewardship and Resistance Programs in
Jamaica’s Center of Excellence Hospitals.
Diabetes, Digestive and Liver Disease Program
Dr. Morse and Dr. Lombardo presenting at the University Diabetes Outreach Program
The University of the West Indies is structuring a program that
includes screening, diagnostics, treatment and prevention related
to cardiovascular, diabetes, renal, infectious, social and
nutritional causes of digestive and liver disease.
The program will include medical, surgical, nutritional and
treatment components and could become a national model for regional
implementation. CIGBS will help establish a stakeholder group to
guide the development of viral hepatitis research projects and to
facilitate a liver disease conference to be held in 2016.
Cannabinoid Sciences and Clinical Applications Research Program
The UWI is a regional and global leader in conducting clinical
research on cannabinoid treatment. Its scientists and researchers
are developing best practices for quality assurance and patient
monitoring that will establish national guidelines for optimal
cannabinoid use. Clinical experts from endocrinology, primary care,
pharmacologic sciences, nanotechnology, behavioral sciences and
patient safety are collaborating on this initiative.
Cancer Research in Natural Products and Nanomedicine
UWI will establish a multidisciplinary program to identify
indigenous compounds with anticancer properties. The university
also will develop nanomedicine approaches—innovative
formulation and tissue-targeted nanocarrier systems—that
maximize therapeutic benefit and minimize drug toxicity. The
program will bring together researchers and clinicians in
biochemistry, analytical chemistry, proteomics, bioengineering,
nanotechnology and pharmaceutical sciences to develop, patent and
commercialize cancer diagnostics and therapeutics.